AI
ISEE

Atom Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Atom Investors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,829
Closed -$553K – 357
2022
Q3 		$553K Buy
+30,829
New +$405K 0.19% 141

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atom Investors's ISEE Position: Q4 2022 in Review

Atom Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 30,829 shares — an estimated $553K sold.

Atom Investors first reported a position in ISEE in Q3 2022 and held it in 1 quarter. The position peaked at $553K in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Atom Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Atom Investors sold 30,829 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $553K.
  • Atom Investors first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Atom Investors's IVERIC bio, Inc. Common Stock position peaked at $553K in Q3 2022.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Atom Investors's 13F filing for Q4 2022, filed 14 Feb 2023.